These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Correlated studies of a recombinant influenza-virus vaccine. II. Definition of antigenicity in experimental animals. Schulman JL; Kilbourne ED J Infect Dis; 1971 Nov; 124(5):463-72. PubMed ID: 5115670 [No Abstract] [Full Text] [Related]
3. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. Harmon MW; Rota PA; Walls HH; Kendal AP J Clin Microbiol; 1988 Feb; 26(2):333-7. PubMed ID: 3343328 [TBL] [Abstract][Full Text] [Related]
4. Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man. Couch RB; Douglas RG; Fedson DS; Kasel JA J Infect Dis; 1971 Nov; 124(5):473-80. PubMed ID: 5000515 [No Abstract] [Full Text] [Related]
5. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees. Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671 [No Abstract] [Full Text] [Related]
6. Studies on inactivated influenza vaccines. II. Effect of increasing dosage on antibody response and adverse reactions in man. Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS; Hierholzer JC Am J Epidemiol; 1970 Oct; 92(4):248-56. PubMed ID: 5458217 [No Abstract] [Full Text] [Related]
7. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man. Barry DW; Mayner RE; Staton E; Dunlap RC; Rastogi SC; Hannah JE; Blackburn RJ; Nortman DF; Graze PR Am J Epidemiol; 1976 Jul; 104(1):34-46. PubMed ID: 947145 [TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. Mogabgab WJ; Leiderman E JAMA; 1970 Mar; 211(10):1672-6. PubMed ID: 4984268 [No Abstract] [Full Text] [Related]
9. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity. Gwaltney JM; Edmondson WP; Rothenberg R; White PW Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719 [No Abstract] [Full Text] [Related]
10. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine. Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093 [No Abstract] [Full Text] [Related]
11. Evaluation of immune responses to inactivated influenza vaccines prepared in embryonated chicken eggs and MDCK cells in a mouse model. Nerome K; Kumihashi H; Nerome R; Hiromoto Y; Yokota Y; Ueda R; Omoe K; Chiba M Dev Biol Stand; 1999; 98():53-63; discussion 73-4. PubMed ID: 10494959 [TBL] [Abstract][Full Text] [Related]
12. Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination. Liu F; Gross FL; Jefferson SN; Holiday C; Bai Y; Wang L; Zhou B; Levine MZ J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33690218 [TBL] [Abstract][Full Text] [Related]
13. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)]. Pressler K; Schenk KD Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655 [No Abstract] [Full Text] [Related]
14. [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine]. Smolonogina TA; Desheva IuA; Shaldzhian AA; Grudinin MP; Rudenko LG Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):72-6. PubMed ID: 22308734 [TBL] [Abstract][Full Text] [Related]
15. Inactivated vaccines. 1. Volunteer studies with very high doses of influenza vaccine purified by zonal ultracentrifugation. Mostow SR; Schoenbaum SC; Dowdle WR; Coleman MT; Kaye HS Postgrad Med J; 1973 Mar; 49(569):152-8. PubMed ID: 4802501 [TBL] [Abstract][Full Text] [Related]
16. [Antineuraminidase antibodies in influenza infection and vaccination with inactivated vaccines]. Profeta ML; Zanetti A; Bergamini F Boll Ist Sieroter Milan; 1972; 51(3):190-9. PubMed ID: 4653136 [No Abstract] [Full Text] [Related]
17. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R mBio; 2017 Sep; 8(5):. PubMed ID: 28928215 [TBL] [Abstract][Full Text] [Related]
18. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine. Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864 [TBL] [Abstract][Full Text] [Related]
19. Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines. Shin D; Park KJ; Lee H; Cho EY; Kim MS; Hwang MH; Kim SI; Ahn DH Virus Res; 2015 Jun; 204():40-6. PubMed ID: 25892718 [TBL] [Abstract][Full Text] [Related]
20. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children. Hosai H; Omura S; Maeda A; Kunita N Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350 [No Abstract] [Full Text] [Related] [Next] [New Search]